Búsqueda | Portal de Búsqueda de la BVS España

1.

Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.

Strickland, Matthew R; Lander, Eric M; Gibson, Michael K; Ilson, David H; Ajani, Jaffer A; Klempner, Samuel J.

J Natl Compr Canc Netw; 22(3)2024 03 19.

Artículo en Inglés | MEDLINE | ID: mdl-38503041

2.

First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.

Cytryn, Samuel L; Moy, Ryan H; Cowzer, Darren; Shah, Ronak H; Chou, Joanne F; Joshi, Smita S; Ku, Geoffrey Y; Maron, Steven B; Desai, Avni; Yang, Jessica; Sugarman, Ryan; Rao, Devika; Goldberg, Zoe; Charalambous, Carmelina; Lapshina, Maria; Antoine, Ariel; Socolow, Fiona; Trivedi, Nikhil; Capanu, Marinela; Gerdes, Hans; Schattner, Mark A; Simmons, Marc; Lacouture, Mario E; Paroder, Viktoriya; Tang, Laura H; Shia, Jinru; Ilson, David H; Solit, David B; Berger, Michael F; Janjigian, Yelena Y.

Lancet Oncol; 24(10): 1073-1082, 2023 10.

Artículo en Inglés | MEDLINE | ID: mdl-37666264

3.

Survival of Locally Advanced MSI-high Gastric Cancer Patients Treated With Perioperative Chemotherapy: A Retrospective Cohort Study.

Vos, Elvira L; Maron, Steven B; Krell, Robert W; Nakauchi, Masaya; Fiasconaro, Megan; Capanu, Marinela; Walch, Henry S; Chatila, Walid K; Schultz, Nikolaus; Ilson, David H; Janjigian, Yelena Y; Ku, Geoffrey Y; Yoon, Sam S; Coit, Daniel G; Vanderbilt, Chad M; Tang, Laura H; Strong, Vivian E.

Ann Surg; 277(5): 798-805, 2023 05 01.

Artículo en Inglés | MEDLINE | ID: mdl-35766391

4.

Waiting to Operate: The Risk of Salvage Esophagectomy.

Boerner, Thomas; Harrington, Caitlin; Tan, Kay See; Adusumilli, Prasad S; Bains, Manjit S; Bott, Matthew J; Downey, Robert J; Huang, James; Ilson, David H; Isbell, James M; Janjigian, Yelena Y; Park, Bernard J; Rocco, Gaetano; Rusch, Valerie W; Sihag, Smita; Wu, Abraham J; Jones, David R; Molena, Daniela.

Ann Surg; 277(5): 781-788, 2023 05 01.

Artículo en Inglés | MEDLINE | ID: mdl-36727949

5.

Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal Adenocarcinoma.

Carr, Rebecca A; Hsu, Meier; Harrington, Caitlin A; Tan, Kay See; Bains, Manjit S; Bott, Matthew J; Ilson, David H; Isbell, James M; Janjigian, Yelena Y; Maron, Steven B; Park, Bernard J; Rusch, Valerie W; Sihag, Smita; Wu, Abraham J; Jones, David R; Ku, Geoffrey Y; Molena, Daniela.

Ann Surg; 277(3): e538-e544, 2023 03 01.

Artículo en Inglés | MEDLINE | ID: mdl-34387205

6.

Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II Study.

Cowzer, Darren; Wu, Abraham Jing-Ching; Sihag, Smita; Walch, Henry S; Park, Bernard J; Jones, David R; Gu, Ping; Maron, Steven B; Sugarman, Ryan; Chalasani, Sree Bhavani; Shcherba, Marina; Capanu, Marinela; Chou, Joanne F; Choe, Jennie K; Nosov, Anton; Adusumilli, Prasad S; Yeh, Randy; Tang, Laura H; Ilson, David H; Janjigian, Yelena Y; Molena, Daniela; Ku, Geoffrey Y.

Ann Surg; 278(3): e511-e518, 2023 09 01.

Artículo en Inglés | MEDLINE | ID: mdl-36762546

7.

Advances in the treatment of gastric cancer: 2022-2023.

Ilson, David H.

Curr Opin Gastroenterol; 39(6): 517-521, 2023 Nov 01.

Artículo en Inglés | MEDLINE | ID: mdl-37678195

8.

Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

Ajani, Jaffer A; D'Amico, Thomas A; Bentrem, David J; Cooke, David; Corvera, Carlos; Das, Prajnan; Enzinger, Peter C; Enzler, Thomas; Farjah, Farhood; Gerdes, Hans; Gibson, Michael; Grierson, Patrick; Hofstetter, Wayne L; Ilson, David H; Jalal, Shadia; Keswani, Rajesh N; Kim, Sunnie; Kleinberg, Lawrence R; Klempner, Samuel; Lacy, Jill; Licciardi, Frank; Ly, Quan P; Matkowskyj, Kristina A; McNamara, Michael; Miller, Aaron; Mukherjee, Sarbajit; Mulcahy, Mary F; Outlaw, Darryl; Perry, Kyle A; Pimiento, Jose; Poultsides, George A; Reznik, Scott; Roses, Robert E; Strong, Vivian E; Su, Stacey; Wang, Hanlin L; Wiesner, Georgia; Willett, Christopher G; Yakoub, Danny; Yoon, Harry; McMillian, Nicole R; Pluchino, Lenora A.

J Natl Compr Canc Netw; 21(4): 393-422, 2023 04.

Artículo en Inglés | MEDLINE | ID: mdl-37015332

9.

Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.

Safran, Howard P; Winter, Kathryn; Ilson, David H; Wigle, Dennis; DiPetrillo, Thomas; Haddock, Michael G; Hong, Theodore S; Leichman, Lawrence P; Rajdev, Lakshmi; Resnick, Murray; Kachnic, Lisa A; Seaward, Samantha; Mamon, Harvey; Diaz Pardo, Dayssy Alexandra; Anderson, Carryn M; Shen, Xinglei; Sharma, Anand K; Katz, Alan W; Salo, Jonathan; Leonard, Kara L; Moughan, Jennifer; Crane, Christopher H.

Lancet Oncol; 23(2): 259-269, 2022 02.

Artículo en Inglés | MEDLINE | ID: mdl-35038433

10.

Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer.

Yu, Kenneth H; Park, Jennifer; Mittal, Avni; Abou-Alfa, Ghassan K; El Dika, Imane; Epstein, Andrew S; Ilson, David H; Kelsen, David P; Ku, Geoffrey Y; Li, Jia; Park, Wungki; Varghese, Anna M; Chou, Joanne F-L; Capanu, Marinela; Cooper, Brandon; Bartlett, Andrew; McCarthy, Devan; Sangar, Vineet; McCarthy, Brian; O'Reilly, Eileen M.

Cancer; 128(15): 2958-2966, 2022 08 01.

Artículo en Inglés | MEDLINE | ID: mdl-35647938

11.

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

Ajani, Jaffer A; D'Amico, Thomas A; Bentrem, David J; Chao, Joseph; Cooke, David; Corvera, Carlos; Das, Prajnan; Enzinger, Peter C; Enzler, Thomas; Fanta, Paul; Farjah, Farhood; Gerdes, Hans; Gibson, Michael K; Hochwald, Steven; Hofstetter, Wayne L; Ilson, David H; Keswani, Rajesh N; Kim, Sunnie; Kleinberg, Lawrence R; Klempner, Samuel J; Lacy, Jill; Ly, Quan P; Matkowskyj, Kristina A; McNamara, Michael; Mulcahy, Mary F; Outlaw, Darryl; Park, Haeseong; Perry, Kyle A; Pimiento, Jose; Poultsides, George A; Reznik, Scott; Roses, Robert E; Strong, Vivian E; Su, Stacey; Wang, Hanlin L; Wiesner, Georgia; Willett, Christopher G; Yakoub, Danny; Yoon, Harry; McMillian, Nicole; Pluchino, Lenora A.

J Natl Compr Canc Netw; 20(2): 167-192, 2022 02.

Artículo en Inglés | MEDLINE | ID: mdl-35130500

12.

Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS).

Shitara, Kohei; Doi, Toshihiko; Hosaka, Hisashi; Thuss-Patience, Peter; Santoro, Armando; Longo, Federico; Ozyilkan, Ozgur; Cicin, Irfan; Park, David; Zaanan, Aziz; Pericay, Carles; Özgüroglu, Mustafa; Alsina, Maria; Makris, Lukas; Benhadji, Karim A; Ilson, David H.

Gastric Cancer; 25(3): 586-597, 2022 05.

Artículo en Inglés | MEDLINE | ID: mdl-34997449

13.

Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of Recurrence.

Nakauchi, Masaya; Vos, Elvira; Tang, Laura H; Gonen, Mithat; Janjigian, Yelena Y; Ku, Geoffrey Y; Ilson, David H; Maron, Steven B; Yoon, Sam S; Brennan, Murray F; Coit, Daniel G; Strong, Vivian E.

Ann Surg Oncol; 28(9): 4829-4838, 2021 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-33566242

14.

Association of Obesity with Worse Operative and Oncologic Outcomes for Patients Undergoing Gastric Cancer Resection.

Nakauchi, Masaya; Vos, Elvira L; Tang, Laura H; Gonen, Mithat; Janjigian, Yelena Y; Ku, Geoffrey Y; Ilson, David H; Maron, Steven B; Yoon, Sam S; Brennan, Murray F; Coit, Daniel G; Strong, Vivian E.

Ann Surg Oncol; 28(12): 7040-7050, 2021 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-33830355

15.

Advances in the treatment of gastric cancer: 2020-2021.

Ilson, David H.

Curr Opin Gastroenterol; 37(6): 615-618, 2021 11 01.

Artículo en Inglés | MEDLINE | ID: mdl-34456227

16.

Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.

Mansoor, Wasat; Arkenau, Hendrik-Tobias; Alsina, Maria; Shitara, Kohei; Thuss-Patience, Peter; Cuffe, Sinead; Dvorkin, Mikhail; Park, David; Ando, Takayuki; Van Den Eynde, Marc; Beretta, Giordano D; Zaniboni, Alberto; Doi, Toshihiko; Tabernero, Josep; Ilson, David H; Makris, Lukas; Benhadji, Karim A; Van Cutsem, Eric.

Gastric Cancer; 24(4): 970-977, 2021 07.

Artículo en Inglés | MEDLINE | ID: mdl-33713215

17.

Immunotherapy in esophagogastric cancer.

Ilson, David H.

Clin Adv Hematol Oncol; 19(10): 639-647, 2021 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-34637430

18.

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial.

Janjigian, Yelena Y; Maron, Steven B; Chatila, Walid K; Millang, Brittanie; Chavan, Shweta S; Alterman, Carly; Chou, Joanne F; Segal, Michal F; Simmons, Marc Z; Momtaz, Parisa; Shcherba, Marina; Ku, Geoffrey Y; Zervoudakis, Alice; Won, Elizabeth S; Kelsen, David P; Ilson, David H; Nagy, Rebecca J; Lanman, Richard B; Ptashkin, Ryan N; Donoghue, Mark T A; Capanu, Marinela; Taylor, Barry S; Solit, David B; Schultz, Nikolaus; Hechtman, Jaclyn F.

Lancet Oncol; 21(6): 821-831, 2020 06.

Artículo en Inglés | MEDLINE | ID: mdl-32437664

19.

Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer.

Moy, Ryan H; Dos Santos Fernandes, Gustavo; Jonsson, Philip; Chou, Joanne F; Basunia, Azfar; Ku, Geoffrey Y; Chalasani, Sree B; Boyar, Michelle S; Goldberg, Zoe; Desai, Avni M; Gabler, Amelia; Berger, Michael F; Tang, Laura H; Hechtman, Jaclyn F; Kelsen, David P; Schattner, Mark; Ilson, David H; Solit, David B; Taylor, Barry S; Schultz, Nikolaus; Capanu, Marinela; Janjigian, Yelena Y.

Oncologist; 25(1): e68-e74, 2020 01.

Artículo en Inglés | MEDLINE | ID: mdl-31570517

20.

Advances in the treatment of gastric cancer.

Ilson, David H.

Curr Opin Gastroenterol; 36(6): 525-529, 2020 11.

Artículo en Inglés | MEDLINE | ID: mdl-32889823

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.

First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.

Survival of Locally Advanced MSI-high Gastric Cancer Patients Treated With Perioperative Chemotherapy: A Retrospective Cohort Study.

Waiting to Operate: The Risk of Salvage Esophagectomy.

Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal Adenocarcinoma.

Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II Study.

Advances in the treatment of gastric cancer: 2022-2023.

Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.

Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer.

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS).

Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of Recurrence.

Association of Obesity with Worse Operative and Oncologic Outcomes for Patients Undergoing Gastric Cancer Resection.

Advances in the treatment of gastric cancer: 2020-2021.

Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.

Immunotherapy in esophagogastric cancer.

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial.

Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer.

Advances in the treatment of gastric cancer.